Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Tissue-Drug Binding: Localization of Drugs and its Significance

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Enhanced Delivery of Aurora Kinase A Inhibitor Alisertib via Tumor-Targeting Immunoliposome Nanocomplex for Improved Treatment of Cancers Including Atypical Teratoid/Rhabdoid Tumor.

International journal of nanomedicine·2026

Same author

RELT Is Upregulated in Breast Cancer and Induces Death in Breast Cancer Cells.

Biomedicines·2025

Same author

scL-2PAM: A Novel Countermeasure That Ameliorates Neuroinflammation and Neuronal Losses in Mice Exposed to an Anticholinesterase Organophosphate.

International journal of molecular sciences·2024

Same author

SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors.

International journal of nanomedicine·2024

Same author

A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate.

International journal of nanomedicine·2024

Same author

A Novel P53 Nanomedicine Reduces Immunosuppression and Augments Anti-PD-1 Therapy for Non-Small Cell Lung Cancer in Syngeneic Mouse Models.

Cells·2022

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Does a targeting ligand influence nanoparticle tumor localization or uptake?

Kathleen F Pirollo¹, Esther H Chang

¹Department of Oncology, Georgetown University Medical Center, Washington DC 20057-1469, USA.

Trends in Biotechnology

|August 30, 2008

Summary

Tumor-targeting molecules in nanodelivery systems enhance efficacy but their role in tumor localization versus cellular uptake requires further study. The presence of polyethylene glycol (PEG) and its effect on the enhanced permeability and retention (EPR) effect may be key factors.

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jul 2, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Area of Science:

Biomedical Engineering
Nanotechnology
Pharmacology

Background:

Nanosized delivery systems with tumor-targeting molecules show increased in vivo efficacy.
The precise role of these targeting molecules in biodistribution and pharmacokinetics remains unclear.
Existing literature presents conflicting findings on whether ligands primarily enhance intracellular uptake or influence tumor localization.

Purpose of the Study:

To investigate the influence of tumor-targeting molecules on nanoparticle biodistribution and pharmacokinetics.
To clarify the role of targeting ligands in tumor localization versus intracellular uptake.
To explore the impact of poly-[ethylene glycol] (PEG) and the enhanced permeability and retention (EPR) effect on targeted nanoparticle delivery.

Main Methods:

Analysis of existing literature on nanoparticle targeting and delivery.
Comparative assessment of studies with and without poly-[ethylene glycol] (PEG) modification.
Evaluation of the enhanced permeability and retention (EPR) effect in nanoparticle accumulation.

Main Results:

Tumor-targeting ligands may primarily enhance intracellular uptake rather than tumor localization.
The presence or absence of poly-[ethylene glycol] (PEG) might differentiate nanoparticle behavior.
The enhanced permeability and retention (EPR) effect is a critical factor influenced by nanoparticle composition.

Conclusions:

Further research is essential to fully understand the complex interplay between nanoparticle composition, targeting ligands, and tumor delivery.
Elucidating these factors will optimize the design of effective tumor-targeted nanodelivery systems.
The influence of poly-[ethylene glycol] (PEG) on the EPR effect warrants detailed investigation for improved therapeutic outcomes.